<p>The EU's drug watchdog on Monday approved booster doses of Moderna's Covid vaccine for all over-18s, amid concerns that protection levels dip after initial jabs.</p>.<p>Spikevax is the second booster to be given the green light after Pfizer/Biontech's Comirnaty jab earlier this month.</p>.<p>"Data showed that a third dose of Spikevax given six to eight months after the second dose led to a rise in antibody levels in adults whose antibody levels were waning," the European Medicines Agency said.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/world-news-politics/us-fda-authorises-pfizer-jj-booster-doses-allows-mix-and-match-covid-19-vaccination-strategy-1042669.html" target="_blank">US FDA authorises Pfizer, J&J booster doses; allows mix and match Covid-19 vaccination strategy</a></strong></p>.<p>Public health bodies within the 27-member bloc "may issue official recommendations on the use of booster doses, taking into account the local epidemiological situation", the Amsterdam-based EMA said.</p>.<p>It added that current data showed a pattern of side effects similar to that which followed a second dose of Spikevax.</p>.<p>"The risk of inflammatory heart conditions and other very rare side effects after a booster is being carefully monitored."</p>.<p>Earlier this month, the EU medicines watchdog approved booster shots of Comirnaty for over-18s as well as extra doses of Comirnaty and Spikevax for people with severely weakened immune systems.</p>.<p><strong>Check out latest coronavirus-related videos from <i data-stringify-type="italic">DH</i>:</strong></p>
<p>The EU's drug watchdog on Monday approved booster doses of Moderna's Covid vaccine for all over-18s, amid concerns that protection levels dip after initial jabs.</p>.<p>Spikevax is the second booster to be given the green light after Pfizer/Biontech's Comirnaty jab earlier this month.</p>.<p>"Data showed that a third dose of Spikevax given six to eight months after the second dose led to a rise in antibody levels in adults whose antibody levels were waning," the European Medicines Agency said.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/world-news-politics/us-fda-authorises-pfizer-jj-booster-doses-allows-mix-and-match-covid-19-vaccination-strategy-1042669.html" target="_blank">US FDA authorises Pfizer, J&J booster doses; allows mix and match Covid-19 vaccination strategy</a></strong></p>.<p>Public health bodies within the 27-member bloc "may issue official recommendations on the use of booster doses, taking into account the local epidemiological situation", the Amsterdam-based EMA said.</p>.<p>It added that current data showed a pattern of side effects similar to that which followed a second dose of Spikevax.</p>.<p>"The risk of inflammatory heart conditions and other very rare side effects after a booster is being carefully monitored."</p>.<p>Earlier this month, the EU medicines watchdog approved booster shots of Comirnaty for over-18s as well as extra doses of Comirnaty and Spikevax for people with severely weakened immune systems.</p>.<p><strong>Check out latest coronavirus-related videos from <i data-stringify-type="italic">DH</i>:</strong></p>